Bioequivalence study of amodiaquine hydrochloride tablets

• In: SIG Bioavailability/Bioequivalence - Posters
• At: Beijing (China) (2007)
• Type: Poster
• Poster code: BB-P-044
• By: ZHONG, Dafang (Shanghai Institute of Materia Medica, Shanghai, China)
• Co-author(s): Chen, Xiaoyan (Shanghai Institute of Materia Medica, SHANGHAI, China)
  Dai, Xiaojian (Shanghai Institute of Materia Medica, SHANGHAI, China)
  Gao, Zhiwei (Shanghai Institute of Materia Medica, SHANGHAI, China)
  
• Abstract:

  OBJECTIVE To determine the bioequivalence of Amodiaquine Hydrochloride Tablets (test product) of Guilin Pharmaceutical Co., Ltd, China as compared to FlavoquineÂ[RSYMBOL] Tablets (reference product) of Laboratoire Aventis, France. METHODS The study was conducted as an open-label randomized, two-treatment, two-period, cross-over single-dose study..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login